Literature DB >> 20521845

Cytidylyl and uridylyl cyclase activity of bacillus anthracis edema factor and Bordetella pertussis CyaA.

Martin Göttle1, Stefan Dove, Frieder Kees, Jens Schlossmann, Jens Geduhn, Burkhard König, Yuequan Shen, Wei-Jen Tang, Volkhard Kaever, Roland Seifert.   

Abstract

Cyclic adenosine 3',5'-monophosphate (cAMP) and cyclic guanosine 3',5'-monophosphate (cGMP) are second messengers for numerous mammalian cell functions. The natural occurrence and synthesis of a third cyclic nucleotide (cNMP), cyclic cytidine 3',5'-monophosphate (cCMP), is a matter of controversy, and almost nothing is known about cyclic uridine 3',5'-monophosphate (cUMP). Bacillus anthracis and Bordetella pertussis secrete the adenylyl cyclase (AC) toxins edema factor (EF) and CyaA, respectively, weakening immune responses and facilitating bacterial proliferation. A cell-permeable cCMP analogue inhibits human neutrophil superoxide production. Here, we report that EF and CyaA also possess cytidylyl cyclase (CC) and uridylyl cyclase (UC) activity. CC and UC activity was determined by a radiometric assay, using [alpha-(32)P]CTP and [alpha-(32)P]UTP as substrates, respectively, and by a high-performance liquid chromatography method. The identity of cNMPs was confirmed by mass spectrometry. On the basis of available crystal structures, we developed a model illustrating conversion of CTP to cCMP by bacterial toxins. In conclusion, we have shown both EF and CyaA have a rather broad substrate specificity and exhibit cytidylyl and uridylyl cyclase activity. Both cCMP and cUMP may contribute to toxin actions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20521845      PMCID: PMC2951761          DOI: 10.1021/bi100684g

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  37 in total

1.  Kinetic analysis of cyclic CMP-specific and multifunctional phosphodiesterases by quantitative positive-ion fast-atom bombardment mass spectrometry.

Authors:  R P Newton; M A Bayliss; J A Khan; A Bastani; A C Wilkins; D E Games; T J Walton; A G Brenton; F M Harris
Journal:  Rapid Commun Mass Spectrom       Date:  1999       Impact factor: 2.419

2.  Estimation of cytidylyl cyclase activity and monitoring of side-product formation by fast-atom bombardment mass spectrometry.

Authors:  R P Newton; N Groot; J van Geyschem; P E Diffley; T J Walton; M A Bayliss; F M Harris; D E Games; A G Brenton
Journal:  Rapid Commun Mass Spectrom       Date:  1997       Impact factor: 2.419

3.  Interactions of forskolin and ATP with the cytosolic domains of mammalian adenylyl cyclase.

Authors:  C W Dessauer; T T Scully; A G Gilman
Journal:  J Biol Chem       Date:  1997-08-29       Impact factor: 5.157

Review 4.  Bordatella pertussis adenylate cyclase: a toxin with multiple talents.

Authors:  D Ladant; A Ullmann
Journal:  Trends Microbiol       Date:  1999-04       Impact factor: 17.079

5.  Broad specificity of mammalian adenylyl cyclase for interaction with 2',3'-substituted purine- and pyrimidine nucleotide inhibitors.

Authors:  Tung-Chung Mou; Andreas Gille; Srividya Suryanarayana; Mark Richter; Roland Seifert; Stephen R Sprang
Journal:  Mol Pharmacol       Date:  2006-06-09       Impact factor: 4.436

6.  Cytidylate cyclase: development of assay and determination of kinetic properties of a cytidine 3',5'-cyclic monophosphate-synthesizing enzyme.

Authors:  R P Newton; B J Salvage; N A Hakeem
Journal:  Biochem J       Date:  1990-01-15       Impact factor: 3.857

7.  Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infection.

Authors:  Yuequan Shen; Natalia L Zhukovskaya; Michael I Zimmer; Sandriyana Soelaiman; Pamela Bergson; Chyung-Ru Wang; Craig S Gibbs; Wei-Jen Tang
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-20       Impact factor: 11.205

8.  2'(3')-O-(N-methylanthraniloyl)-substituted GTP analogs: a novel class of potent competitive adenylyl cyclase inhibitors.

Authors:  Andreas Gille; Roland Seifert
Journal:  J Biol Chem       Date:  2003-02-03       Impact factor: 5.157

9.  Functional consequences of single amino acid substitutions in calmodulin-activated adenylate cyclase of Bordetella pertussis.

Authors:  P Glaser; H Munier; A M Gilles; E Krin; T Porumb; O Bârzu; R Sarfati; C Pellecuer; A Danchin
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

10.  Thermodynamics of binding of divalent magnesium and manganese to uridine phosphates: implications for diabetes-related hypomagnesaemia and carbohydrate biocatalysis.

Authors:  Corbin J Zea; Gulden Camci-Unal; Nicola L Pohl
Journal:  Chem Cent J       Date:  2008-07-15       Impact factor: 4.215

View more
  32 in total

1.  Inhibition of the adenylyl cyclase toxin, edema factor, from Bacillus anthracis by a series of 18 mono- and bis-(M)ANT-substituted nucleoside 5'-triphosphates.

Authors:  Hesham Taha; Stefan Dove; Jens Geduhn; Burkhard König; Yuequan Shen; Wei-Jen Tang; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-09-24       Impact factor: 3.000

2.  Structure-activity relationships for the interactions of 2'- and 3'-(O)-(N-methyl)anthraniloyl-substituted purine and pyrimidine nucleotides with mammalian adenylyl cyclases.

Authors:  Cibele Pinto; Gerald H Lushington; Mark Richter; Andreas Gille; Jens Geduhn; Burkhard König; Tung-Chung Mou; Stephen R Sprang; Roland Seifert
Journal:  Biochem Pharmacol       Date:  2011-05-18       Impact factor: 5.858

Review 3.  The Pseudomonas aeruginosa Exoenzyme Y: A Promiscuous Nucleotidyl Cyclase Edema Factor and Virulence Determinant.

Authors:  K Adam Morrow; Dara W Frank; Ron Balczon; Troy Stevens
Journal:  Handb Exp Pharmacol       Date:  2017

4.  Lipopolysaccharide-induced pulmonary endothelial barrier disruption and lung edema: critical role for bicarbonate stimulation of AC10.

Authors:  Jordan Nickols; Boniface Obiako; K C Ramila; Kevin Putinta; Sarah Schilling; Sarah L Sayner
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-10-16       Impact factor: 5.464

5.  cUMP hydrolysis by PDE3A.

Authors:  Stefan Berrisch; Jessica Ostermeyer; Volkhard Kaever; Solveig Kälble; Denise Hilfiker-Kleiner; Roland Seifert; Erich H Schneider
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-12-14       Impact factor: 3.000

6.  Pseudomonas aeruginosa exotoxin Y is a promiscuous cyclase that increases endothelial tau phosphorylation and permeability.

Authors:  Cristhiaan D Ochoa; Mikhail Alexeyev; Viktoriya Pastukh; Ron Balczon; Troy Stevens
Journal:  J Biol Chem       Date:  2012-05-25       Impact factor: 5.157

7.  Heterogeneity of pulmonary endothelial cyclic nucleotide response to Pseudomonas aeruginosa ExoY infection.

Authors:  K A Morrow; R Seifert; V Kaever; A L Britain; S L Sayner; C D Ochoa; E A Cioffi; D W Frank; T C Rich; T Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-09-18       Impact factor: 5.464

8.  B. anthracis edema toxin increases cAMP levels and inhibits phenylephrine-stimulated contraction in a rat aortic ring model.

Authors:  Yan Li; Xizhong Cui; Steven B Solomon; Kenneth Remy; Yvonne Fitz; Peter Q Eichacker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-12       Impact factor: 4.733

9.  Empirical valence bond simulations of the chemical mechanism of ATP to cAMP conversion by anthrax edema factor.

Authors:  Letif Mones; Wei-Jen Tang; Jan Florián
Journal:  Biochemistry       Date:  2013-04-02       Impact factor: 3.162

10.  cCMP is a substrate for MRP5.

Authors:  Svenja Laue; Moritz Winterhoff; Volkhard Kaever; Jeroen J van den Heuvel; Frans G Russel; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-07-15       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.